Serum markers in breast cancer and colorectal cancer (1997)
Bellet, D.; Mlika-Cabanne, N.; Bedenne, L.; Brun, B.; Demeaux, J.L.; Legrand, J.L.; Lorimier, G.; Mignotte, H.; Ollivier, J.M.; Piperno-Neumann, S.; Rinaldi, Y.; Rousset, H.; Rymer, J.C.; Laversin, S.
Gynecologie Obstetrique and Fertilite 29(1): 62-63
2001
ISSN/ISBN: 1297-9589 PMID: 11217195 Document Number: 533962
Document emailed within 1 workday
Related Documents
Li, Y. 2008: Rational use of clinical detection of serum tumor markers in diagnosis of colorectal cancer Zhonghua Yi Xue Za Zhi 88(29): 2023-2024Eskelinen, M.; Kataja, V.; Hämäläinen, E.; Kosma, V.M.; Penttilä, I.; Alhava, E. 1997: Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer Anticancer Research 17(2b): 1231-1234
Schuurman, J.J.; Bong, S.B.; Einarsson, R. 1996: Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients Anticancer Research 16(4b): 2169-2172
Lantzsch, T.; Hefler, L.; Krause, U.; Kehl, A.; Goepel, C.; Koelbl, H.; Dunst, J.; Lampe, D. 2002: The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer Anticancer Research 22(3): 1925-1928
Khalil, S.; Ceccarelli, F. 2009: Colorectal cancer after breast cancer: magnitude of risk in clinical practice and in the literature Tumori 95(1): 28-31
Messina, G.; Lissoni, P.; Brivio, F.; Rovelli, F.; Fumagalli, L.; Bartolacelli, E.; Mazza, U.; Colombo, E.; Bertoglio, A. 2008: A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour In Vivo 22(6): 845-848
Zissimopoulos, A.; Matthaios, D.; Matthaiou, E.; Mantadakis, E.; Karaitianos, I. 2007: Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients Journal of BUON: Official Journal of the Balkan Union of Oncology 12(4): 505-511
Jakovljevic, M.; Gutzwiller, F.; Schwenkglenks, M.; Milovanovic, O.; Rancic, N.; Varjacic, M.; Stojadinovic, D.; Dagovic, A.; Matter-Walstra, K. 2014: Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 1111-1120
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Yamamoto, H.; Miyake, Y.; Noura, S.; Ogawa, M.; Yasui, M.; Ikenaga, M.; Sekimoto, M.; Monden, M. 2001: Tumor markers for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(9): 1299-1305
Gorgone, S.; Alleruzzo, A.; Rizzo, A.G.; Labruto, G.; Di Pietro, N.; Sampiero, G.; Barbuscia, M.; Arsena, A. 1992: Tumor markers in colorectal cancer Minerva Chirurgica 47(15-16): 1249-1252
Burn, J.; Chapman, P.D.; Bishop, D.T.; Smalley, S.; Mickleburgh, I.; West, S.; Mathers, J.C. 2001: Susceptibility markers in colorectal cancer Iarc Scientific Publications 154: 131-147
Baron, J.A. 2001: Intermediate effect markers for colorectal cancer Iarc Scientific Publications 154: 113-129
Lech, G.; Slotwinski, R.; Krasnodebski, I.W. 2014: The role of tumor markers and biomarkers in colorectal cancer Neoplasma 61(1): 1-8
Koda, M.; Kanczuga-Koda, L.; Reszec, J.; Sulkowska, M.; Famulski, W.; Baltaziak, M.; Kisielewski, W.; Sulkowski, S. 2004: Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer Folia Morphologica 63(3): 337-341
Naritaka, Y.; Ogawa, K.; Matsumoto, N.; Hosokawa, T.; Kikuchi, T.; Koyama, N.; Haga, S.; Kajiwara, T.; Sakakibara, N. 1987: Clinical evaluation of tumor markers in patients with colorectal cancer Gan no Rinsho. Japan Journal of Cancer Clinics 33(10): 1274-1280
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Aaltonen, L.A.; Sankila, R.; Mecklin, J.P.; Järvinen, H.; Pukkala, E.; Peltomäki, P.; de la Chapelle, A. 1994: A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden Cancer Detection and Prevention 18(1): 57-63
Kawahara, D.; Fujita, F.; Hayashi, H.; Matsuyama, T.; Eguchi, S. 2015: The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection Hepato-Gastroenterology 62(139): 624-628
Volchenko, N.N.; Litvinova, L.V.; Pugachev, K.K.; Shimbireva, I.B.; Kalashnikov, V.V.; Frank, G.A. 1996: Immunomorphologic markers in breast cancer Arkhiv Patologii 58(1): 6-10